What smart money is saying about Astrana Health
ASTH
No fund has written a full thesis on Astrana Health in our archive, but 2 fund letters report a position in it — most recently Diamond Hill Small Cap Fund in June 2026.
Get an email when a fund writes about it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Between Q4 2024 and Q2 2026, 2 fund letters reported a position in Astrana Health, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q4 2024 | 1 | 0 | 0 | 0 |
Fund activity · 2 positions
- June 2026
“• Astrana Health, a leader in value-based health care, outperformed as the company results have continued to demonstrate that it was not taking advantage of loopholes within Medicare coding, the balance sheet is back in good shape after the recent Prospect Health acquisition, which is performing well, and recent Medicare Advantage rates came in better than expected.”
Astrana Health - December 2024
“Other bottom Q4 contributors included Astrana Health, Live Oak Bancshares and Rocky Brands.”
Astrana Health
Read the letters behind these Astrana Health positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger